[1]
Udovicich, C., Nankivell, P., Barberi, A., Page, D., Jenkins, M., Goad, J., Clarke, A., Niall, O., Temelcos, C., Cleeve, L. and Wong, L.-M. 2017. BCG immunotherapy for non-muscle invasive bladder cancer: is efficacy related to toxicity?. Bladder. 4, 1 (Jan. 2017), e27. DOI:https://doi.org/10.14440/bladder.2017.96.